遇见数据集

Dataset related to sub-study one of the PainSMART-project (RCT-PROMs primary and secondary outcomes).

收藏
Zenodo2026-02-27 更新2026-05-26 收录
官方服务:

资源简介:

Data supporting the results of this study comprise patient reported outcome measures (PROMs) and baseline information used as covariates in adjusted models. Data were collected for the two groups (PainSMART-group and Control Group) via online questionnaires at four time points: Baseline, follow-up 1 (24-72 hours pre-initial physiotherapy consultation), follow-up 2 (24 hours post-initial physiotherapy consultation) and follow-up 3 (three months post-baseline). The following PROMs were collected: Primary outcomes - Average pain intensity in the last 24 hours (NRS-average pain, 0-10). - Pain self-efficacy (Pain Self Efficacy Questionnaire, PSEQ-10, 0-60). Secondary outcomes - Best pain intensity in the last 24 hours (NRS-best pain, 0-10). - Worst pain intensity in the last 24 hours (NRS-worst pain, 0-10). - MSKP-related illness perceptions (Brief Illness Perception Questionnaire, BIPQ, 0-80). - MSKP-management strategies (Brief Pain Coping Inventory-2:SWE Traditional Pain Management Strategies subscale, BPCI-2:SWE TPMS, 0-56). - Psychological flexibility (BPCI-2:SWE Psychological Flexibility, PF-subscale, 0-77). - Reassurance of the benign nature of MSKP (NRS-reassurance, 0-10). - Self-reported physical activity levels in the preceding week (FASTA-score, 3-19). - Self-reported sitting time (hours per day, 0-16hrs). - Global rating of change scale (GRoC, -5 to +5). The following baseline covariates were used to adjust the models. Age, biological sex, body-mass-index, highest educational level, comorbidities (yes/no), work status (working/not working), sickness absence (absent/not absent), pain duration (acute/chronic with 3-month cut-off), pain localisation (regional pain/widespread pain), time from baseline to consultation (days), healthcare consultations for presenting MSKP in preceding 3-months (yes/no), Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) risk category (high >50 points or low ≤50), analgesic use (yes/no).

提供机构:
Zenodo
创建时间:
2026-02-27
二维码
社区交流群
二维码
科研交流群
商业服务